Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
40.99
+0.04 (0.10%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Apellis Pharmaceuticals Analyst Ratings
Total Analysts
21
Consensus Rating
Hold
Price Target
$33.59
Upside
-18.05%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $26 → $41 | Buy → Hold | Downgrades | $26 → $41 | +0.02% | Apr 17, 2026 |
| Mizuho | Mizuho | Hold Maintains $20 → $41 | Hold | Maintains | $20 → $41 | +0.02% | Apr 2, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 1, 2026 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $37 → $41 | Buy → Hold | Downgrades | $37 → $41 | +0.02% | Apr 1, 2026 |
| Barclays | Barclays | Hold Maintains $24 → $41 | Hold | Maintains | $24 → $41 | +0.02% | Apr 1, 2026 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 1, 2026 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $44 → $41 | Strong Buy → Hold | Downgrades | $44 → $41 | +0.02% | Apr 1, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $48 → $41 | Strong Buy → Hold | Downgrades | $48 → $41 | +0.02% | Apr 1, 2026 |
| Needham | Needham | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 31, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $35 → $31 | Buy | Maintains | $35 → $31 | -24.37% | Mar 18, 2026 |
| Roth Capital | Roth Capital | Strong Sell → Strong Buy Initiates $31 | Strong Sell → Strong Buy | Initiates | $31 | -24.37% | Mar 13, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $36 → $37 | Buy | Maintains | $36 → $37 | -9.73% | Mar 5, 2026 |
| Mizuho | Mizuho | Hold Maintains $19 → $20 | Hold | Maintains | $19 → $20 | -51.21% | Mar 5, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $45 → $44 | Strong Buy | Maintains | $45 → $44 | +7.34% | Feb 25, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $22 → $21 | Hold | Maintains | $22 → $21 | -48.77% | Feb 25, 2026 |
| Wedbush | Wedbush | Hold Maintains $20 → $18 | Hold | Maintains | $20 → $18 | -56.09% | Feb 25, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.